Mind Medicine (MindMed) Inc. (MNMD) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 101 transactions totaling $2.4M, demonstrating a bearish sentiment with -$2.3M in net insider flow. The most recent transaction on Dec 26, 2025 involved a sale of 11,276 shares valued at $148.3K.
No significant insider buying has been recorded for MNMD in the recent period.
No significant insider selling has been recorded for MNMD in the recent period.
Based on recent SEC filings, insider sentiment for MNMD is bearish with an Insider Alignment Score of 1/100 and a net flow of -$2.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Mind Medicine (MindMed) Inc. (MNMD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading MNMD stock, having executed 101 transactions in the past 90 days. The most active insider is Robert Barrow (Executive), who has made 33 transactions totaling $1.6M.
Get notified when executives and directors at MNMD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 26, 2025 | Sullivan Mark | Executive | Sale | 11,276 | $13.15 | $148.3K | |
| Dec 26, 2025 | Barrow Robert | Executive | Sale | 25,791 | $13.15 | $339.2K | |
| Dec 26, 2025 | Karlin Daniel | Executive | Sale | 5,600 | $13.15 | $73.6K | |
| Sep 25, 2025 | Karlin Daniel | Executive | Sale | 7,704 | $9.77 | $75.3K | |
| Sep 25, 2025 | Barrow Robert | Executive | Sale | 25,797 | $9.77 | $252.0K | |
| Sep 25, 2025 | Sullivan Mark | Executive | Sale | 11,278 | $9.77 | $110.2K | |
| Sep 25, 2024 | Sullivan Mark | Executive | Sale | 4,430 | $5.98 | $26.5K | 10b5-1 |
| Sep 25, 2024 | Karlin Dan | Executive | Sale | 6,871 | $5.98 | $41.1K | 10b5-1 |
| Sep 25, 2024 | Barrow Robert | Executive | Sale | 19,771 | $5.98 | $118.2K | 10b5-1 |
| Sep 25, 2024 | Liao Carrie | Executive | Sale | 2,352 | $5.98 | $14.1K | 10b5-1 |
| Aug 23, 2024 | W. Gryska David | Executive | Purchase | 3,500 | $5.98 | $20.9K | |
| Aug 21, 2024 | Miri Halperin Wernli | Executive | Option Exercise | 50,000 | $3.70 | $185.0K | |
| Aug 21, 2024 | Miri Halperin Wernli | Executive | Payment | 32,595 | $6.17 | $201.1K | |
| Aug 20, 2024 | Barrow Robert | Executive | Purchase | 500 | $6.12 | $3.1K | |
| Aug 19, 2024 | Barrow Robert | Executive | Purchase | 500 | $6.31 | $3.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 57 | $2.4M | 72.2% |
Payment(F) | 10 | $691.8K | 21.2% |
Exercise(M) | 1 | $185.0K | 5.7% |
Purchase(P) | 3 | $27.1K | 0.8% |
Award(A) | 29 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at Mind Medicine (MindMed) Inc. has increased, with 15 insiders executing 101 transactions across all time. Total sales of $2.4M significantly outpace purchases of $27.1K, resulting in a net outflow of $2.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.